Cargando…

Neutrophil elastase in bronchiectasis

The role of neutrophil elastase (NE) is poorly understood in bronchiectasis because of the lack of preclinical data and so most of the assumptions made about NE inhibitor potential benefit is based on data from CF. In this context, NE seems to be a predictor of long-term clinical outcomes and a poss...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gramegna, Andrea, Amati, Francesco, Terranova, Leonardo, Sotgiu, Giovanni, Tarsia, Paolo, Miglietta, Daniela, Calderazzo, Maria Adelaide, Aliberti, Stefano, Blasi, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735855/ https://www.ncbi.nlm.nih.gov/pubmed/29258516 http://dx.doi.org/10.1186/s12931-017-0691-x

Ejemplares similares

The biology of pulmonary exacerbations in bronchiectasis
por: Amati, Francesco, et al.
Publicado: (2019)

Prevalence and incidence of bronchiectasis in Italy
por: Aliberti, Stefano, et al.
Publicado: (2020)

Nontuberculous mycobacteria infection and pulmonary disease in bronchiectasis
por: Suska, Kseniia, et al.
Publicado: (2022)

T2-High Endotype and Response to Biological Treatments in Patients with Bronchiectasis
por: Oriano, Martina, et al.
Publicado: (2021)

Pro-resolving and pro-inflammatory fatty acid-derived mediators in sputum of stable state bronchiectasis patients
por: Terranova, Leonardo, et al.
Publicado: (2022)

Protease–Antiprotease Imbalance in Bronchiectasis
por: Oriano, Martina, et al.
Publicado: (2021)

SARS-CoV-2 vaccines: A critical perspective through efficacy data and barriers to herd immunity
por: Blasi, Francesco, et al.
Publicado: (2021)

Comparison of different sets of immunological tests to identify treatable immunodeficiencies in adult bronchiectasis patients
por: Aliberti, Stefano, et al.
Publicado: (2022)

Clinical applications of azithromycin microspheres in respiratory tract infections
por: Blasi, Francesco, et al.
Publicado: (2007)

When and how ruling out cystic fibrosis in adult patients with bronchiectasis
por: Gramegna, Andrea, et al.
Publicado: (2018)

Mixed community-acquired lower respiratory tract infections
por: Tarsia, Paolo, et al.
Publicado: (2007)

The Isoform GC1f of the Vitamin D Binding Protein Is Associated with Bronchiectasis Severity
por: Oriano, Martina, et al.
Publicado: (2021)

Efficacy of Pirfenidone and Nintedanib in Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis: A Systematic Review
por: Amati, Francesco, et al.
Publicado: (2023)

Efficacy and effectiveness of Ceftaroline Fosamil in patients with pneumonia: a systematic review and meta-analysis
por: Sotgiu, Giovanni, et al.
Publicado: (2018)

Why, when and how to investigate primary ciliary dyskinesia in adult patients with bronchiectasis
por: Contarini, Martina, et al.
Publicado: (2018)

Comparison of different conditions for DNA extraction in sputum - a pilot study
por: Oriano, Martina, et al.
Publicado: (2019)

Genetic and Serum Screening for Alpha-1-Antitrypsin Deficiency in Adult Patients with Cystic Fibrosis: A Single-Center Experience
por: Amati, Francesco, et al.
Publicado: (2022)

Microbial Dysregulation of the Gut-Lung Axis in Bronchiectasis
por: Narayana, Jayanth Kumar, et al.
Publicado: (2022)

Innate and Adaptive Lymphocytes in Non-Tuberculous Mycobacteria Lung Disease: A Review
por: Gramegna, Andrea, et al.
Publicado: (2022)

Sputum neutrophil elastase and its relation to pediatric bronchiectasis severity: A cross‐sectional study
por: Ali, Heba A., et al.
Publicado: (2022)

Long-Term Domiciliary High-Flow Nasal Therapy in Patients with Bronchiectasis: A Preliminary Retrospective Observational Case-Control Study
por: Crimi, Claudia, et al.
Publicado: (2022)

Prulifloxacin: a brief review of its potential in the treatment of acute exacerbation of chronic bronchitis
por: Blasi, Francesco, et al.
Publicado: (2007)

Heterogeneity of weight gain after initiation of Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosis
por: Gramegna, Andrea, et al.
Publicado: (2023)

Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia
por: Amati, Francesco, et al.
Publicado: (2023)

Once daily aerosolised tobramycin in adult patients with cystic fibrosis in the management of Pseudomonas aeruginosa chronic infection
por: Mantero, Marco, et al.
Publicado: (2017)

Characterizing Non-Tuberculous Mycobacteria Infection in Bronchiectasis
por: Faverio, Paola, et al.
Publicado: (2016)

Personalised anti-inflammatory therapy for bronchiectasis and cystic fibrosis: selecting patients for controlled trials of neutrophil elastase inhibition
por: Keir, Holly R., et al.
Publicado: (2019)

Walking the path of treatable traits in interstitial lung diseases
por: Amati, Francesco, et al.
Publicado: (2023)

Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective
por: Gramegna, Andrea, et al.
Publicado: (2018)

Correction to: Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective
por: Gramegna, Andrea, et al.
Publicado: (2020)

From Ivacaftor to Triple Combination: A Systematic Review of Efficacy and Safety of CFTR Modulators in People with Cystic Fibrosis
por: Gramegna, Andrea, et al.
Publicado: (2020)

Get together to increase awareness in bronchiectasis: a report of the 2(nd) World Bronchiectasis Conference
por: Aliberti, Stefano, et al.
Publicado: (2018)

Severe asthma exacerbation: role of acute Chlamydophila pneumoniae and Mycoplasma pneumoniae infection
por: Cosentini, Roberto, et al.
Publicado: (2008)

Helmet CPAP treatment in patients with COVID-19 pneumonia: a multicentre cohort study
por: Aliberti, Stefano, et al.
Publicado: (2020)

The Role of Neutrophils and Neutrophil Elastase in Pneumococcal Pneumonia
por: Domon, Hisanori, et al.
Publicado: (2021)

Alpha-1 antitrypsin deficiency as a common treatable mechanism in chronic respiratory disorders and for conditions different from pulmonary emphysema? A commentary on the new European Respiratory Society statement
por: Gramegna, Andrea, et al.
Publicado: (2018)

Nontuberculous Mycobacteria in Noncystic Fibrosis Bronchiectasis
por: Bonaiti, Giulia, et al.
Publicado: (2015)

Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients
por: Di Pasquale, Marta Francesca, et al.
Publicado: (2019)

Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
por: Amati, Francesco, et al.
Publicado: (2022)

Management of Acute Respiratory Failure Due to Community-Acquired Pneumonia: A Systematic Review
por: Vanoni, Nicolò Maria, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_h6dep9aa71pn6u49jkls1rs23c